Vanni Borghi

Summary

Affiliation: University of Modena and Reggio Emilia
Country: Italy

Publications

  1. doi Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir
    V Borghi
    Clinic of Infectious and Tropical Diseases, Azienda Ospedaliero Universitaria Policlinico di Modena, University of Modena and Reggio Emilia, Via del Pozzo, 71, 41100, Modena, Italy
    Infection 41:425-9. 2013
  2. ncbi HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3
    Vanni Borghi
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Antivir Ther 13:1057-65. 2008
  3. ncbi Late presenters in an HIV surveillance system in Italy during the period 1992-2006
    Vanni Borghi
    Department of Internal Medicine, Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    J Acquir Immune Defic Syndr 49:282-6. 2008
  4. ncbi Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system
    Elisa Nemes
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 20:2021-32. 2006
  5. ncbi Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 19:1627-33. 2005
  6. pmc T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy
    Andrea Cossarizza
    Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy
    PLoS ONE 7:e50728. 2012
  7. doi Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection
    Elisa Nemes
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via Campi 287, Modena, Italy
    AIDS 24:947-57. 2010
  8. ncbi Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients
    Milena Nasi
    Department of Biomedical Sciences, Chair of Immunology, University of Modena and Reggio Emilia, Via Campi 287, Modena, 41100, Italy
    Immunogenetics 57:628-35. 2005
  9. ncbi Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection
    Andrea Cossarizza
    Department of Biomedical Sciences, Section of General Pathology, University of Modena and Reggio Emilia School of Medicine, Modena, Italy
    J Acquir Immune Defic Syndr 35:213-22. 2004
  10. ncbi Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation
    Andrea Cossarizza
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy
    Mitochondrion 11:750-5. 2011

Detail Information

Publications20

  1. doi Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir
    V Borghi
    Clinic of Infectious and Tropical Diseases, Azienda Ospedaliero Universitaria Policlinico di Modena, University of Modena and Reggio Emilia, Via del Pozzo, 71, 41100, Modena, Italy
    Infection 41:425-9. 2013
    ..We retrospectively investigated the presence of steatosis among HIV-HCV co-infected and HCV mono-infected patients, and the role of tenofovir disoproxil fumarate (TDF) or abacavir (ABC) in determining hepatic steatosis...
  2. ncbi HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3
    Vanni Borghi
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Antivir Ther 13:1057-65. 2008
    ..We analysed the effect of HIV coinfection and antiretroviral therapy on hepatic steatosis and the effect of the steatosis on fibrosis in patients with or without HCV genotype 3 infection...
  3. ncbi Late presenters in an HIV surveillance system in Italy during the period 1992-2006
    Vanni Borghi
    Department of Internal Medicine, Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    J Acquir Immune Defic Syndr 49:282-6. 2008
    ..We also identify risk factors associated with presenting at late stages of HIV disease...
  4. ncbi Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system
    Elisa Nemes
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 20:2021-32. 2006
    ..To investigate immunological changes during CD4-guided therapy interruption in HIV(+) patients who suspended HAART...
  5. ncbi Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 19:1627-33. 2005
    ..HIV infection per se and HAART can alter mitochondrial functionality, leading to a decrease in mitochondrial DNA content...
  6. pmc T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy
    Andrea Cossarizza
    Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy
    PLoS ONE 7:e50728. 2012
    ..Our objective was to characterize the polyfunctionality of immune response triggered by PHI, and to characterize immune activation and regulatory T cells, correlating such features to disease progression...
  7. doi Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection
    Elisa Nemes
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via Campi 287, Modena, Italy
    AIDS 24:947-57. 2010
    ..The activity of virus-specific T lymphocytes, among which those capable of a polyfunctional response against the viral protein gag, is crucial to control HIV infection...
  8. ncbi Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients
    Milena Nasi
    Department of Biomedical Sciences, Chair of Immunology, University of Modena and Reggio Emilia, Via Campi 287, Modena, 41100, Italy
    Immunogenetics 57:628-35. 2005
    ....
  9. ncbi Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection
    Andrea Cossarizza
    Department of Biomedical Sciences, Section of General Pathology, University of Modena and Reggio Emilia School of Medicine, Modena, Italy
    J Acquir Immune Defic Syndr 35:213-22. 2004
    ..Our results indicate that HAART can restore the T-cell repertoire in individuals whose immune system is not severely compromised by the infection...
  10. ncbi Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation
    Andrea Cossarizza
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy
    Mitochondrion 11:750-5. 2011
    ....
  11. ncbi CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, Azienda Ospedaliero Universitaria Policlinico, University of Modena and Reggio Emilia, Via del Pozzo, 71, 41100 Modena, Italy
    AIDS 19:287-94. 2005
    ..Little is known about CD4 cell count changes in patients with high CD4 cell counts who interrupt antiretroviral therapy, especially in those with a nadir of 250-350 x 10 cells/l...
  12. doi Patients presenting with AIDS in the HAART era: a collaborative cohort analysis
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, and Azienda Policlinico, Modena, Italy
    AIDS 22:2461-9. 2008
    ..Many patients infected with HIV still present with an AIDS diagnosis. The aim of this study was to evaluate the virological, immunological and clinical outcomes of HAART in these patients...
  13. ncbi Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption
    Cristina Mussini
    Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy
    J Acquir Immune Defic Syndr 52:588-94. 2009
    ..The extent of immune reconstitution following HAART resumption after 1 cycle of treatment interruption (TI) is not well known...
  14. ncbi Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy
    Clin Infect Dis 38:565-71. 2004
    ..Recurrent cryptococcal infection should be suspected in patients whose serum cryptococcal antigen test results revert back to positive after discontinuation of maintenance therapy...
  15. ncbi Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy
    Giovanni Guaraldi
    Department of Medicine and Medical Specialties, Infectious Diseases Clinic, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy
    HIV Clin Trials 7:97-106. 2006
    ..Treatment for metabolic and morphologic alterations in HIV-related lipodystrophy include medical therapy, physical exercise, and surgical interventions...
  16. ncbi Predictive value of intracellular HIV-1 DNA levels during CD4-guided treatment interruption in HIV+ patients
    Milena Nasi
    Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    AIDS Res Hum Retroviruses 26:553-8. 2010
    ..In conclusion, intracellular HIV-1 DNA is a predictive marker for the length of CD4-guided TI...
  17. ncbi Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy
    Cristina Mussini
    Infectious Diseases Clinic, University of Modena and Reggio Emilia School of Medicine and Azienda Ospedaliera Policlinico Modena, Modena, Italy
    AIDS 16:1609-16. 2002
    ..To identify crucial immunological characteristics of a group of patients, defined 'CD4-exploders', who were able to fully reconstitute their immune system after receiving highly active antiretroviral therapy (HAART)...
  18. ncbi Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Modena, Italy
    AIDS 16:1551-4. 2002
    ..This decline was unrelated to the CD4 cell count and HIV-RNA values at interruption, but was more profound in patients in whom the M184V mutation had disappeared after lamivudine discontinuation...
  19. ncbi Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group
    Cristina Mussini
    Clinic of Infectious and Tropical Diseases, Azienda Ospedaliera Policlinico, University of Modena and Reggio Emilia, Modena, Italy
    Clin Infect Dis 36:645-51. 2003
    ..Patients who present with symptoms after discontinuation of secondary prophylaxis should be evaluated for PCP despite high CD4 count and complete virus suppression...
  20. ncbi Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study
    Giovanni Guaraldi
    HIV Metabolic Clinic, Department of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Italy
    Antivir Ther 10:753-9. 2005
    ..To compare autologous fat transfer (AFT), injections of reabsorbable [polylactic acid (PLA)] and non-reabsorbable [polyacrylamide hydrogel (PAAG)] filler materials for the treatment of HIV-related facial lipoatrophy...